Relx Plc $RELX Shares Bought by Ethic Inc.

Ethic Inc. increased its position in Relx Plc (NYSE:RELX) by 14.0% during the third quarter, Holdings Channel.com reports. The firm owned 150,600 shares of the technology company’s stock after buying an additional 18,464 shares during the quarter. Ethic Inc.’s holdings in Relx were worth $4,997,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of RELX. Parallel Advisors LLC raised its holdings in Relx by 4.3% during the third quarter. Parallel Advisors LLC now owns 9,824 shares of the technology company’s stock worth $326,000 after buying an additional 408 shares during the last quarter. May Hill Capital LLC bought a new position in shares of Relx in the third quarter valued at $267,000. Alps Advisors Inc. lifted its stake in shares of Relx by 4.4% in the third quarter. Alps Advisors Inc. now owns 21,040 shares of the technology company’s stock valued at $698,000 after buying an additional 891 shares in the last quarter. Heritage Family Offices LLP acquired a new position in shares of Relx during the third quarter valued at about $85,000. Finally, Argonautica Private Wealth Management Inc. grew its holdings in shares of Relx by 5.1% during the third quarter. Argonautica Private Wealth Management Inc. now owns 19,079 shares of the technology company’s stock valued at $633,000 after buying an additional 929 shares during the last quarter. Institutional investors and hedge funds own 15.02% of the company’s stock.

Relx Price Performance

NYSE RELX opened at $39.98 on Tuesday. The business has a fifty day simple moving average of $36.41 and a 200 day simple moving average of $34.52. Relx Plc has a 12 month low of $27.57 and a 12 month high of $43.36. The company has a debt-to-equity ratio of 5.23, a current ratio of 0.45 and a quick ratio of 0.40.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Zacks Research raised shares of Relx from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, September 30th. Weiss Ratings restated a “hold (c)” rating on shares of Relx in a report on Wednesday, November 4th. Sanford C. Bernstein reaffirmed a “buy” rating on shares of Relx in a research report on Tuesday, October 6th. UBS Group reiterated a “buy” rating on shares of Relx in a research note on Tuesday, September 29th. Finally, TD Cowen assumed coverage on Relx in a research note on Thursday, September 10th. They set a “buy” rating for the company. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

Relx Profile

RELX plc is a global provider of information, analytics and decision tools for professional and business customers. Its operations are organized around scientific, technical and medical information; legal information and analytics; risk solutions; and exhibitions.

The company’s products and services include scientific journals and research platforms such as ScienceDirect and Scopus, legal research tools including LexisNexis, and analytics that help organizations assess risks, verify identities and detect fraud.